324 related articles for article (PubMed ID: 35661856)
1. Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial.
Basch E; Schrag D; Henson S; Jansen J; Ginos B; Stover AM; Carr P; Spears PA; Jonsson M; Deal AM; Bennett AV; Thanarajasingam G; Rogak LJ; Reeve BB; Snyder C; Bruner D; Cella D; Kottschade LA; Perlmutter J; Geoghegan C; Samuel-Ryals CA; Given B; Mazza GL; Miller R; Strasser JF; Zylla DM; Weiss A; Blinder VS; Dueck AC
JAMA; 2022 Jun; 327(24):2413-2422. PubMed ID: 35661856
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
3. Electronic patient-reported outcomes monitoring during lung cancer chemotherapy: A nested cohort within the PRO-TECT pragmatic trial (AFT-39).
Mody GN; Stover AM; Wang M; King-Kallimanis BL; Jansen J; Henson S; Chung AE; Jonsson M; Bennett A; Smith AB; Wood WA; Deal A; Ginos B; Dueck AC; Schrag D; Basch E
Lung Cancer; 2021 Dec; 162():1-8. PubMed ID: 34634754
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
[TBL] [Abstract][Full Text] [Related]
6. Effect of a Home-Based Exercise Intervention of Wearable Technology and Telephone Coaching on Walking Performance in Peripheral Artery Disease: The HONOR Randomized Clinical Trial.
McDermott MM; Spring B; Berger JS; Treat-Jacobson D; Conte MS; Creager MA; Criqui MH; Ferrucci L; Gornik HL; Guralnik JM; Hahn EA; Henke P; Kibbe MR; Kohlman-Trighoff D; Li L; Lloyd-Jones D; McCarthy W; Polonsky TS; Skelly C; Tian L; Zhao L; Zhang D; Rejeski WJ
JAMA; 2018 Apr; 319(16):1665-1676. PubMed ID: 29710165
[TBL] [Abstract][Full Text] [Related]
7. Electronic Patient-Reported Outcome Monitoring to Improve Quality of Life After Joint Replacement: Secondary Analysis of a Randomized Clinical Trial.
Steinbeck V; Langenberger B; Schöner L; Wittich L; Klauser W; Mayer M; Kuklinski D; Vogel J; Geissler A; Pross C; Busse R
JAMA Netw Open; 2023 Sep; 6(9):e2331301. PubMed ID: 37656459
[TBL] [Abstract][Full Text] [Related]
8. Financial Toxicity Monitoring in a Randomized Controlled Trial of Patient-Reported Outcomes During Cancer Treatment (Alliance AFT-39).
Blinder VS; Deal AM; Ginos B; Jansen J; Dueck AC; Mazza GL; Henson S; Carr P; Rogak LJ; Weiss A; Rapperport A; Jonsson M; Spears PA; Cella D; Gany F; Schrag D; Basch E
J Clin Oncol; 2023 Oct; 41(29):4652-4663. PubMed ID: 37625107
[TBL] [Abstract][Full Text] [Related]
9. Early Physical Therapy vs Usual Care in Patients With Recent-Onset Low Back Pain: A Randomized Clinical Trial.
Fritz JM; Magel JS; McFadden M; Asche C; Thackeray A; Meier W; Brennan G
JAMA; 2015 Oct; 314(14):1459-67. PubMed ID: 26461996
[TBL] [Abstract][Full Text] [Related]
10. Nurse and Social Worker Palliative Telecare Team and Quality of Life in Patients With COPD, Heart Failure, or Interstitial Lung Disease: The ADAPT Randomized Clinical Trial.
Bekelman DB; Feser W; Morgan B; Welsh CH; Parsons EC; Paden G; Baron A; Hattler B; McBryde C; Cheng A; Lange AV; Au DH
JAMA; 2024 Jan; 331(3):212-223. PubMed ID: 38227034
[TBL] [Abstract][Full Text] [Related]
11. Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT Trial.
Basch E; Stover AM; Schrag D; Chung A; Jansen J; Henson S; Carr P; Ginos B; Deal A; Spears PA; Jonsson M; Bennett AV; Mody G; Thanarajasingam G; Rogak LJ; Reeve BB; Snyder C; Kottschade LA; Charlot M; Weiss A; Bruner D; Dueck AC
JCO Clin Cancer Inform; 2020 Oct; 4():947-957. PubMed ID: 33112661
[TBL] [Abstract][Full Text] [Related]
12. Effect of Brain Metastasis on Patient-Reported Outcomes in Advanced NSCLC Treated in Real-World Community Oncology Settings.
Walker MS; Wong W; Ravelo A; Miller PJE; Schwartzberg LS
Clin Lung Cancer; 2018 Mar; 19(2):139-147. PubMed ID: 29103883
[TBL] [Abstract][Full Text] [Related]
13. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
14. Effect of a Symptom Monitoring Intervention for Patients Hospitalized With Advanced Cancer: A Randomized Clinical Trial.
Nipp RD; Horick NK; Qian CL; Knight HP; Kaslow-Zieve ER; Azoba CC; Elyze M; Landay SL; Kay PS; Ryan DP; Jackson VA; Greer JA; El-Jawahri A; Temel JS
JAMA Oncol; 2022 Apr; 8(4):571-578. PubMed ID: 35142814
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.
Galle PR; Finn RS; Qin S; Ikeda M; Zhu AX; Kim TY; Kudo M; Breder V; Merle P; Kaseb A; Li D; Mulla S; Verret W; Xu DZ; Hernandez S; Ding B; Liu J; Huang C; Lim HY; Cheng AL; Ducreux M
Lancet Oncol; 2021 Jul; 22(7):991-1001. PubMed ID: 34051880
[TBL] [Abstract][Full Text] [Related]
16. Effect of an Individually Tailored and Home-Based Intervention in the Chronic Phase of Traumatic Brain Injury: A Randomized Clinical Trial.
Borgen IMH; Løvstad M; Hauger SL; Forslund MV; Kleffelgård I; Andelic N; Sveen U; Søberg HL; Sigurdardottir S; Winter L; Lindstad MØ; Brunborg C; Røe C
JAMA Netw Open; 2023 May; 6(5):e2310821. PubMed ID: 37145600
[TBL] [Abstract][Full Text] [Related]
17. Pilot randomized trial of an electronic symptom monitoring intervention for hospitalized patients with cancer.
Nipp RD; El-Jawahri A; Ruddy M; Fuh C; Temel B; D'Arpino SM; Cashavelly BJ; Jackson VA; Ryan DP; Hochberg EP; Greer JA; Temel JS
Ann Oncol; 2019 Feb; 30(2):274-280. PubMed ID: 30395144
[TBL] [Abstract][Full Text] [Related]
18. Effect of Endobronchial Coils vs Usual Care on Exercise Tolerance in Patients With Severe Emphysema: The RENEW Randomized Clinical Trial.
Sciurba FC; Criner GJ; Strange C; Shah PL; Michaud G; Connolly TA; Deslée G; Tillis WP; Delage A; Marquette CH; Krishna G; Kalhan R; Ferguson JS; Jantz M; Maldonado F; McKenna R; Majid A; Rai N; Gay S; Dransfield MT; Angel L; Maxfield R; Herth FJ; Wahidi MM; Mehta A; Slebos DJ;
JAMA; 2016 May 24-31; 315(20):2178-89. PubMed ID: 27179849
[TBL] [Abstract][Full Text] [Related]
19. Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial.
Vogel A; Qin S; Kudo M; Su Y; Hudgens S; Yamashita T; Yoon JH; Fartoux L; Simon K; López C; Sung M; Mody K; Ohtsuka T; Tamai T; Bennett L; Meier G; Breder V
Lancet Gastroenterol Hepatol; 2021 Aug; 6(8):649-658. PubMed ID: 34087115
[TBL] [Abstract][Full Text] [Related]
20. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Garassino MC; Gadgeel S; Esteban E; Felip E; Speranza G; Domine M; Hochmair MJ; Powell S; Cheng SY; Bischoff HG; Peled N; Reck M; Hui R; Garon EB; Boyer M; Wei Z; Burke T; Pietanza MC; Rodríguez-Abreu D
Lancet Oncol; 2020 Mar; 21(3):387-397. PubMed ID: 32035514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
